Events and Conferences

Contact Veristat Now


Request A Proposal

Contact Us

Bio Asia 2023

May 2, 2023

 Meet Veristat at the Bio Asia Taiwan 2023  taking place                         on the 26-30 July 2023 

Read More

MedTech Forum 2023

April 28, 2023

Meet Veristat at the MedTech Forum 2023 taking place on the 30th May – 1st June  2023 

Read More

OCT Conference 2023

April 28, 2023

Meet Veristat at the Outsourcing in Clinical Trials Europe  2023  taking place on the  3th - 4th  May 2023

Read More

Marcus Evans Evolution Summit May 2023

April 20, 2023

Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit

 

 

Read More

ASGCT Annual Meeting 2023

April 18, 2023

Veristat’s John Balser, PhD., will be presenting in the scientific symposium  

 

 

Read More

DIA Global Annual Meeting 2023

April 3, 2023

Attend our Innovation Theater Presentation on Decentralized Clinical Trials

 

 

Read More

Swiss Biotech Day 2023

March 30, 2023

Veristat and SFL, a Veristat company,  will attend the Swiss Biotech Day 2023 

Read More

Updated Webinar  | Future Trends on European Regulations on Medicines

March 9, 2023

 

Veristat and TOPRA hosted  a new updated content webinar on the topic:  Future Trends on European Regulations on Medicines                            

What  You Will Learn

The European Commission announced on 25 November 2020 the adoption of the new Pharmaceutical Strategy for Europe. It is an approach intended to ensure strong, fair competitivity and green industry, fostering patient access to innovative and affordable medicines. It will ensure an autonomous and robust supply chain and a stronger EU voice at the global level by promoting a high level of quality, efficacy and safety standards. 

 

Read More

DIA Conference 2023 | Booth #13

March 9, 2023

Veristat and SFL, a Veristat company,  will attend DIA Europe 2023 

Read More

Event | Marcus Evans Evolution Summit March 2023

February 20, 2023

Meet Veristat thought leaders at this exclusive event

 

 

Read More